BR0211641A - Compostos anti-envelhecimento e de cura de ferimento - Google Patents
Compostos anti-envelhecimento e de cura de ferimentoInfo
- Publication number
- BR0211641A BR0211641A BR0211641-3A BR0211641A BR0211641A BR 0211641 A BR0211641 A BR 0211641A BR 0211641 A BR0211641 A BR 0211641A BR 0211641 A BR0211641 A BR 0211641A
- Authority
- BR
- Brazil
- Prior art keywords
- aging
- inhibitors
- wound healing
- development
- matrix metalloproteinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Abstract
"COMPOSTOS ANTI-ENVELHECIMENTO E DE CURA DE FERIMENTO". A invenção provê inibidores de metaloproteinases de matriz que são úteis para o encorajamento do desenvolvimento de pele saudável e para o tratamento de ferimentos. Os inibidores são peptídeos tendo seq³ências relacionadas a regiões de clivagem das formas de pró-enzima de metaloproteinases de matriz. Os inibidores de peptídeo da invenção podem ser formulados em composições terapêuticas, loções, cremes, cobertura de pele e curativos de ferimento, que facilitam a cura e o desenvolvimento de uma pele saudável, desencorajam a formação de cicatrizes e a formação de rugas e melhoram os efeitos de cura.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31272601P | 2001-08-16 | 2001-08-16 | |
US10/032,376 US7186693B2 (en) | 2001-08-16 | 2001-12-21 | Metalloproteinase inhibitors for wound healing |
US10/153,185 US6906036B2 (en) | 2001-08-16 | 2002-05-21 | Anti-aging and wound healing compounds |
PCT/US2002/026198 WO2003016520A1 (en) | 2001-08-16 | 2002-08-15 | Anti-aging and wound healing compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211641A true BR0211641A (pt) | 2004-07-13 |
Family
ID=46150134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211641-3A BR0211641A (pt) | 2001-08-16 | 2002-08-15 | Compostos anti-envelhecimento e de cura de ferimento |
Country Status (9)
Country | Link |
---|---|
US (2) | US6906036B2 (pt) |
EP (2) | EP1423515A4 (pt) |
KR (4) | KR100944318B1 (pt) |
CN (2) | CN1549722A (pt) |
AU (1) | AU2002324737A1 (pt) |
BR (1) | BR0211641A (pt) |
CA (2) | CA2456158A1 (pt) |
MX (2) | MXPA04001033A (pt) |
WO (2) | WO2003018748A2 (pt) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7094754B2 (en) * | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7071164B2 (en) * | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
US7517857B2 (en) * | 2002-01-29 | 2009-04-14 | Posco | Immune-modulating peptide |
AU2003257089A1 (en) * | 2002-07-31 | 2004-02-16 | University Of Florida | Antimicrobial and antiproteolytic wound dressing |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US7148194B2 (en) * | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
CA2539190A1 (en) * | 2003-07-07 | 2005-01-27 | George F. Vande Woude | Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
GB0518804D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Exudialysis tissue cleanser |
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
GB0325120D0 (en) * | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
US8758313B2 (en) | 2003-10-28 | 2014-06-24 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
JP4815752B2 (ja) | 2004-04-01 | 2011-11-16 | 味の素株式会社 | アミノ酸含有飲食品 |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10413644B2 (en) | 2004-04-27 | 2019-09-17 | Smith & Nephew Plc | Wound treatment apparatus and method |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US8951551B2 (en) * | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
SI1806359T1 (sl) * | 2005-09-05 | 2010-06-30 | Immatics Biotechnologies Gmbh | S tumorjem povezani peptidi ki se vežejo brez izjeme na molekule humanega levkocitnega antigena HLA razred II |
US7645583B2 (en) * | 2005-12-14 | 2010-01-12 | Kimberly-Clark Worldwide, Inc. | Identification of compounds for inhibiting complexation of C-reactive protein with fibronectin |
US20070264354A1 (en) * | 2006-05-09 | 2007-11-15 | Herman Richard M | Treatment of a wound with a vasodilator |
EP2623132B1 (en) | 2007-07-18 | 2016-03-30 | The Board of Trustees of the University of Illionis | Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
US8987212B2 (en) | 2007-08-07 | 2015-03-24 | Muhammed Majeed | Oleanoyl peptide composition and method of treating skin aging |
ES2330291B1 (es) * | 2008-02-29 | 2010-10-18 | Lipotec Sa | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
WO2011044443A2 (en) | 2009-10-09 | 2011-04-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Matricryptic ecm peptides for tissue reconstruction |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
US8435541B2 (en) | 2010-09-02 | 2013-05-07 | Bath & Body Works Brand Management, Inc. | Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities |
PT2431030E (pt) * | 2010-09-17 | 2016-03-14 | Abbell Ab | Tratamento de infeções fúngicas |
US10279007B2 (en) | 2010-11-15 | 2019-05-07 | Oxygenetix Institute, Inc. | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
CA3177929A1 (en) | 2012-12-21 | 2014-06-26 | Astellas Institute For Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
EP3677291B1 (en) | 2013-05-10 | 2024-01-03 | Smith & Nephew PLC | Fluidic connector for irrigation and aspiration of wounds |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
EP3079708A4 (en) | 2013-12-09 | 2017-08-30 | The Board of Trustees of the Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
CN105412916B (zh) * | 2014-09-19 | 2021-04-30 | 达森生物药业有限公司 | 治疗乳腺癌的组合物及其用途 |
CN105477628B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 抗癌组合物及其用途 |
CN105477627B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 治疗前列腺癌的组合物及其用途 |
KR101744959B1 (ko) | 2014-12-05 | 2017-06-12 | (주)케어젠 | 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20200115683A (ko) | 2015-02-05 | 2020-10-07 | 무하메드 마제에드 | 올레아노일 펩티드 조성물 및 콜라겐 증진 |
DK3307296T3 (da) | 2015-06-15 | 2021-12-13 | Univ Leland Stanford Junior | Timp2 til anvendelse til behandling af aldringsassocierede tilstande |
PE20191248A1 (es) | 2017-01-27 | 2019-09-18 | Immatics Biotechnologies Gmbh | Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer |
KR102007078B1 (ko) | 2017-03-24 | 2019-08-05 | (주)셀아이콘랩 | 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물 |
EP3703636A1 (en) * | 2017-11-03 | 2020-09-09 | Systagenix Wound Management, Limited | Nutrient-enriched dressing |
KR102087044B1 (ko) * | 2018-04-30 | 2020-03-10 | 인하대학교 산학협력단 | Mmp-10 또는 이를 코딩하는 유전자의 발현을 억제하는 제제를 포함하는 암 전이 억제용 조성물 |
CZ308845B6 (cs) * | 2019-01-21 | 2021-07-07 | Globetech Innovation S.R.O | Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran |
CN111632127B (zh) * | 2019-02-14 | 2022-07-05 | 三凡生技研发股份有限公司 | 短链胜肽组合物及其于皮肤保护的用途 |
CN111748041B (zh) * | 2019-03-11 | 2021-09-14 | 中国科学院苏州纳米技术与纳米仿生研究所 | 微环境控释型功能化水凝胶、其制备方法及应用 |
CN113307851B (zh) * | 2021-06-11 | 2022-04-29 | 珠海医美企业管理有限公司 | 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用 |
CN113698452B (zh) * | 2021-08-23 | 2023-08-18 | 四川丽妍工坊生物科技有限公司 | 一种促皮肤修复肽、制备方法及其应用 |
WO2023080578A1 (ko) * | 2021-11-05 | 2023-05-11 | 주식회사 레메디 | 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도 |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2507379A1 (fr) * | 1981-06-05 | 1982-12-10 | Europ Composants Electron | Bloc de condensateurs en serie et multiplicateur de tension utilisant un tel bloc de condensateurs |
US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
US5270447A (en) * | 1988-05-20 | 1993-12-14 | The United States Of America As Represented By The Department Of Health & Human Services | Metalloproteinase peptides: role in diagnosis and therapy |
US5698671A (en) * | 1989-03-21 | 1997-12-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Metalloproteinase peptides |
AU647459B2 (en) * | 1990-01-26 | 1994-03-24 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A method for quantitatively measuring collagenase |
EP0670849B1 (en) | 1992-10-29 | 2003-08-27 | Bayer Corporation | Diagnostic assay for latent matrix metalloproteinase no. 9 |
JP3098640B2 (ja) | 1992-12-24 | 2000-10-16 | 富士薬品工業株式会社 | ヒト72−kDaゼラチナーゼ/IV型コラゲナーゼの免疫学的定量法 |
JP2673929B2 (ja) | 1993-04-12 | 1997-11-05 | 富士薬品工業株式会社 | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
US6150152A (en) * | 1993-05-28 | 2000-11-21 | Washington University | Human macrophage metalloelastase |
AU7128494A (en) * | 1993-07-09 | 1995-02-06 | Celltech Limited | Gelatinase antagonists used for treating cancer |
JPH07303482A (ja) * | 1993-11-30 | 1995-11-21 | Fuji Yakuhin Kogyo Kk | 新規なメタロプロテアーゼおよびそれをコードするdna |
JPH07159402A (ja) | 1993-12-09 | 1995-06-23 | Kyodo Nyugyo Kk | Iv型コラゲナ−ゼ測定法 |
JPH07330795A (ja) * | 1994-06-07 | 1995-12-19 | Toagosei Co Ltd | ペプチドおよびモノクローナル抗体 |
DE69528614T2 (de) * | 1994-07-07 | 2003-06-18 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft | Modifizierte Proenzyme als Substrate für proteolische Enzyme |
DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
JPH08136548A (ja) | 1994-11-11 | 1996-05-31 | Morinaga & Co Ltd | 泌尿器癌の診断法 |
JPH08134098A (ja) | 1994-11-11 | 1996-05-28 | Morinaga & Co Ltd | ヒトtimp−1の高感度測定法 |
AU708829B2 (en) | 1994-12-13 | 1999-08-12 | Human Genome Sciences, Inc. | Human tissue inhibitor of metalloproteinase-4 |
JP2949467B2 (ja) | 1995-02-16 | 1999-09-13 | 富士薬品工業株式会社 | 免疫学的測定法によるヒトプロマトリックスメタロプロテアーゼ7の定量 |
US5770691A (en) * | 1995-06-05 | 1998-06-23 | Regents Of The University Of Minnesota | Discriminatory substrates for MMP hydrolysis |
JPH0984589A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
JPH0987299A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | Mmp−2活性化因子に特異的なモノクローナル抗体 |
US6191255B1 (en) * | 1995-07-14 | 2001-02-20 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Protein and monoclonal antibody specific thereto |
IT1277904B1 (it) | 1995-08-07 | 1997-11-12 | Polifarma Spa | Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego |
WO1997025437A1 (en) | 1996-01-04 | 1997-07-17 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for assaying proteolytic enzymes using fluorescence-quenched substrates |
JPH09206099A (ja) | 1996-01-31 | 1997-08-12 | Sekisui Chem Co Ltd | 細胞機能測定方法 |
GB9615976D0 (en) | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
US6022948A (en) * | 1996-09-17 | 2000-02-08 | Washington University | Method of cell surface activation and inhibition |
AU5187698A (en) * | 1996-12-06 | 1998-06-29 | Cancerforskningsfondet Af 1989 | Inhibition of invasive remodelling |
EP0988385A2 (en) | 1997-01-21 | 2000-03-29 | Human Genome Sciences | Tace-like and matrilysin-like polypeptides |
JPH10210982A (ja) | 1997-01-31 | 1998-08-11 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
US6017540A (en) * | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
AU6443498A (en) * | 1997-03-07 | 1998-09-22 | Tropix, Inc. | Protease inhibtor assay |
WO1998040475A1 (en) * | 1997-03-11 | 1998-09-17 | Abbott Laboratories | Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same |
US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
AUPO573697A0 (en) | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
JPH10287700A (ja) | 1997-04-10 | 1998-10-27 | Fuji Yakuhin Kogyo Kk | 活性型マトリライシン(mmp−7)に対する抗体及びそれを用いた免疫学的測定法 |
JPH10313896A (ja) | 1997-05-15 | 1998-12-02 | Yamanouchi Pharmaceut Co Ltd | マトリックスメタロプロテアーゼに対する発色団又は蛍光団を有する新規な活性測定用合成基質 |
US6043087A (en) | 1997-07-25 | 2000-03-28 | The New York Blood Center | Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
DE69837516T2 (de) | 1997-11-14 | 2007-12-27 | Murata Mfg. Co., Ltd., Nagaokakyo | Vielschichtkondensator |
AU1931699A (en) | 1997-12-19 | 1999-07-12 | Wyeth | Transgenic animal model for degenerative diseases of cartilage |
FI980604A0 (fi) * | 1998-03-18 | 1998-03-18 | Univ Helsinki Licensing | Nya matrismetalloproteinasinhibitorer och -regulatorer |
US6482802B1 (en) * | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
AU4571099A (en) * | 1998-06-16 | 2000-01-05 | General Hospital Corporation, The | Matrix metalloproteinase proenzyme activator |
US6191225B1 (en) * | 1998-08-31 | 2001-02-20 | Ppg Industries Ohio, Inc. | Thermosetting compositions containing carboxylic acid functional polymers and epoxy functional polymers prepared by atom transfer radical polymerization |
WO2000020860A1 (en) | 1998-10-08 | 2000-04-13 | Calbiochem Novabiochem Corporation | Diagnostic assay for matrix metalloproteinase 9 and use thereof |
DE69941877D1 (de) * | 1998-10-16 | 2010-02-11 | Otsuka Pharma Co Ltd | Neovaskular-spezifische peptide |
USH1973H1 (en) | 1998-10-22 | 2001-07-03 | Novartis Ag | Human neutrophil collagenase splice variant |
KR20010102556A (ko) * | 1999-03-11 | 2001-11-15 | 추후제출 | 암 및 과증식성 장애의 치료 조성물 및 치료방법 |
JP2000270874A (ja) | 1999-03-25 | 2000-10-03 | Fuji Chemical Industries Ltd | 新規な膜結合型メタロプロテアーゼ |
US6274717B1 (en) | 1999-04-20 | 2001-08-14 | Smithkline Beecham Corporation | Splicing variant of human membrane-type matrix metalloproteinease-5 (MT-MMP5-L) |
KR100903243B1 (ko) * | 1999-06-03 | 2009-06-17 | 제시 엘. 에스. 에이유 | 세포증식 및 세포사를 조절하기 위한 방법 및 조성물 |
JP2001072589A (ja) * | 1999-07-06 | 2001-03-21 | Toagosei Co Ltd | 制癌剤 |
KR100509119B1 (ko) * | 1999-07-16 | 2005-08-18 | 주식회사 엘지생활건강 | 프로시아니딘 올리고머를 유효성분으로 하는 약제 |
US6403637B1 (en) | 1999-08-09 | 2002-06-11 | Univ Saint Louis | Methods of modulating matrix metalloproteinase activity and uses thereof |
EP1212075A4 (en) * | 1999-08-26 | 2005-11-23 | Keith M Skubitz | PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF MEMBERS OF THE CD66 FAMILY (CEACAM) |
GB9927576D0 (en) | 1999-11-23 | 2000-01-19 | Univ Birmingham | Novel assay |
US20020063763A1 (en) * | 2000-11-29 | 2002-05-30 | Mantell David Allen | Apparatus and method for removing air bubbles from an ink jet printhead |
US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
AU2001249064A1 (en) | 2000-02-22 | 2001-09-03 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
GB0004531D0 (en) | 2000-02-25 | 2000-04-19 | Richards Andrew J M | The treatment of respiratory diseases |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
US7094754B2 (en) * | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7071164B2 (en) * | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
-
2002
- 2002-05-21 US US10/153,185 patent/US6906036B2/en not_active Expired - Lifetime
- 2002-08-15 CN CNA028151356A patent/CN1549722A/zh active Pending
- 2002-08-15 WO PCT/US2002/026319 patent/WO2003018748A2/en active Application Filing
- 2002-08-15 BR BR0211641-3A patent/BR0211641A/pt not_active IP Right Cessation
- 2002-08-15 KR KR1020097009201A patent/KR100944318B1/ko active IP Right Grant
- 2002-08-15 KR KR10-2004-7001607A patent/KR20040023708A/ko active Search and Examination
- 2002-08-15 AU AU2002324737A patent/AU2002324737A1/en not_active Abandoned
- 2002-08-15 WO PCT/US2002/026198 patent/WO2003016520A1/en active Application Filing
- 2002-08-15 CA CA002456158A patent/CA2456158A1/en not_active Abandoned
- 2002-08-15 MX MXPA04001033A patent/MXPA04001033A/es unknown
- 2002-08-15 KR KR1020107002153A patent/KR100996047B1/ko active IP Right Grant
- 2002-08-15 CA CA002455883A patent/CA2455883A1/en not_active Abandoned
- 2002-08-15 KR KR10-2004-7001667A patent/KR20040028974A/ko not_active Application Discontinuation
- 2002-08-15 CN CN028151348A patent/CN1543503B/zh not_active Expired - Fee Related
- 2002-08-15 EP EP02759388A patent/EP1423515A4/en not_active Withdrawn
- 2002-08-15 EP EP02759399A patent/EP1513542A4/en not_active Withdrawn
- 2002-08-15 MX MXPA04001034A patent/MXPA04001034A/es active IP Right Grant
-
2005
- 2005-01-07 US US11/031,488 patent/US7196162B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100944318B1 (ko) | 2010-03-03 |
MXPA04001033A (es) | 2004-05-27 |
CA2455883A1 (en) | 2003-03-06 |
US6906036B2 (en) | 2005-06-14 |
WO2003018748A2 (en) | 2003-03-06 |
KR20100018107A (ko) | 2010-02-16 |
CN1543503B (zh) | 2011-06-15 |
CN1549722A (zh) | 2004-11-24 |
CN1543503A (zh) | 2004-11-03 |
EP1513542A2 (en) | 2005-03-16 |
KR20040023708A (ko) | 2004-03-18 |
CA2456158A1 (en) | 2003-02-27 |
AU2002324737A1 (en) | 2003-03-10 |
US7196162B2 (en) | 2007-03-27 |
EP1513542A4 (en) | 2009-07-15 |
KR100996047B1 (ko) | 2010-11-22 |
US20050239710A1 (en) | 2005-10-27 |
EP1423515A1 (en) | 2004-06-02 |
WO2003018748A3 (en) | 2004-05-27 |
KR20090051781A (ko) | 2009-05-22 |
WO2003016520A1 (en) | 2003-02-27 |
EP1423515A4 (en) | 2008-02-27 |
KR20040028974A (ko) | 2004-04-03 |
MXPA04001034A (es) | 2004-05-27 |
US20030148959A1 (en) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211641A (pt) | Compostos anti-envelhecimento e de cura de ferimento | |
CY1108633T1 (el) | Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου | |
BRPI9908182B8 (pt) | composições de proteína de matriz para cura de feridas | |
ATE429922T1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
ATE530179T1 (de) | Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
BR0304168A (pt) | Curativo hemostático para ferimentos contendo polissacarìdeo modificado por aldeìdo e agentes hemostáticos | |
BR0013966A (pt) | Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna | |
PT784481E (pt) | Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
BR0110421A (pt) | Polipeptìdeos anti-angiogênicos e métodos para inibir a angiogênese | |
BR9908182A (pt) | Composições de proteìna de matriz para cura deferidas | |
BR9803756A (pt) | Polimento da unha antipsoriático. | |
DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
ES2174039T3 (es) | Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion. | |
DE69607615D1 (de) | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen | |
BR0101486A (pt) | Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas | |
ES2196313T3 (es) | Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los daños agudos inducidos por las radiaciones uv. | |
BR0210428A (pt) | Uso de glicoproteìna para preparação de composições para o tratamento e a reepitelização de feridas | |
BR9809351A (pt) | Tecido de bainha dérmica na cura de lesões | |
ATE526945T1 (de) | Verfahren zur erhöhung von fibronectin | |
BR0010255A (pt) | Formulação farmacêutica, kit de partes, método para tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da trombina e/ou inibição da carboxipeptidase u são requeridas ou desejadas, e, uso de uma formulação | |
DK0951294T3 (da) | Sårhelende formuleringer indeholdende humanplasmafibronectin | |
BR0308040A (pt) | Composições farmacêuticas e cosméticas compreendendo plgf-1 | |
YU31104A (sh) | Inhibicija virusa n-dokozanolom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2164 DE 26/06/2012. |